What A Difference A Year Makes; AI Makes The A-List

The US FDA’s Center for Devices and Radiological Health has announced the guidance documents it plans to focus on in fiscal year 2024, and this time, AI devices make the cut.

Priority List
• Source: Shutterstock

This time last year, Bradley Merrill Thompson was heartbroken over the Food and Drug Administration’s decision not to prioritize guidance on artificial intelligence/machine learning (AI/ML)-enabled device software functions.

In its annual A and B lists of guidance documents it plans to focus on in the coming fiscal year, the FDA’s Center for Devices and Radiological Health (CDRH) put AI/ML devices on the back burner for 2023, which Thompson, an

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

Access To Library Tools Being Restored At US FDA

 

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals and laid off librarians have not been reinstated.

FDA Announces Classifications On 8 Device Types

 
• By 

The US Food and Drug Administration has announced new classifications for eight device types that reached market via the de novo process, with most of the newly classified products in the diagnostics sector.

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.